Live from the NIH registry
Studies recruiting near Jackson right now
Top 25 of 226 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Mississippi Baptist Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fractures: SEXTANT 2
Post Operative Surgical Site Infection
Phase 3
Interventional 600 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Major Extremity Trauma Research Consortium
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
Metabolic Dysfunction-Associated SteatoHepatitis (MASH)
Phase 2
Interventional 120 participants sought
GI Associates — Flowood, Mississippi (4.3 mi)
· Sponsor: Regeneron Pharmaceuticals
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: SWOG Cancer Research Network
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
Chronic Kidney Disease, Heart Failure With Preserved Ejection Fraction (HFPEF)
N/A
Observational 60 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: University of Mississippi Medical Center
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Proven Endpoints — Ridgeland, Mississippi (9.1 mi)
· Sponsor: TriGemX Bio, Inc.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Jackson, Mississippi (2.0 mi)
· Sponsor: Axsome Therapeutics, Inc.
A Mobile Gaming App to Improve Adherence to PrEP
Medication Adherence, HIV/AIDS
N/A
Interventional 200 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Rhode Island Hospital
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Hemorrhagic Shock, Trauma Injury
Phase 3
Interventional 1,000 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Philip Spinella
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Jackson Heart Clinic, P.A. — Jackson, Mississippi (2.0 mi)
· Sponsor: Boehringer Ingelheim
Caris Biorepository Research Protocol
Cancer, Early Detection of Cancer
N/A
Observational 100,000 participants sought
Jackson Oncology Associates — Jackson, Mississippi (2.0 mi)
· Sponsor: Caris Science, Inc.
Zimmer Biomet Shoulder Arthroplasty PMCF
Shoulder Fractures, Shoulder Arthritis
N/A
Interventional 584 participants sought
Mississippi Sports Medicine and Orthopaedic Center, PLLC — Jackson, Mississippi (2.0 mi)
· Sponsor: Zimmer Biomet
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
Bipolar Disorder Type I With Mania
Phase 3
Interventional 450 participants sought
Precise Research Centers — Flowood, Mississippi (4.3 mi)
· Sponsor: Bristol-Myers Squibb
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Relay Therapeutics, Inc.
Follow-up Visit of High Risk Infants
Infant, Newborn, Infant, Low Birth Weight
N/A
Observational 68,000 participants sought
University of Mississippi Medical Center - Children's of Mississippi — Jackson, Mississippi (2.0 mi)
· Sponsor: NICHD Neonatal Research Network
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
Pancreatic Cancer
N/A
Observational 125 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Tissue Reinforcement for Breast Reconstruction (TRBR) Pivotal Clinical Study (REDEFINE)
Breast Reconstruction Surgery
N/A
Interventional 180 participants sought
University of Mississippi — Jackson, Mississippi (2.0 mi)
· Sponsor: W.L.Gore & Associates
THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension
Hypertension
N/A
Interventional 261 participants sought
Jackson Heart Clinic — Jackson, Mississippi (2.0 mi)
· Sponsor: SoniVie Inc.
A Pilot Study of a Remote ADHD Monitoring Program
Attention-deficit/Hyperactivity Disorder, ADHD
N/A
Interventional 36 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: IDeA States Pediatric Clinical Trials Network
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Jackson, Mississippi (2.0 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss
Obesity & Overweight, Mobility Disability
Phase 2
Interventional 200 participants sought
SKY Integrative Medical Center — Ridgeland, Mississippi (9.1 mi)
· Sponsor: Veru Inc.
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
University of Mississippi Medical Center — Jackson, Mississippi (2.0 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
Phase 3
Interventional 2,150 participants sought
Akero Clinical Study Site — Flowood, Mississippi (4.3 mi)
· Sponsor: Akero Therapeutics, Inc